Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences, with warrants trading under the ticker OACCW, is a blank-check company sponsored by an affiliate of Oaktree Capital Management, the Los Angeles-based alternative investment firm with approximately $190 billion in assets under management. The vehicle is focused on the life sciences sector and represents the third SPAC vehicle in Oaktree's acquisition series. The company filed an 8-K with the Securities and Exchange Commission on October 29, 2025, reflecting continued corporate activity as it pursues a qualifying business combination within the healthcare and life sciences industry. For comprehensive filing history, deal timelines, and full sponsor track records, sign up for complete data on SpacDesk.